Therapeutic Resistance in Melanoma: Molecular Mechanisms and Emerging Pharmaceutical Strategies.

Moussallem N, Awada A, El Darzi R, Tarhini A, Khaled A, Ashy C, Nasr W, El Masri A, Saad G, Itani M, Rizkallah J, Charbel N, Hatahet Z, Saade D, Abou Rahal J, Kreidieh F

Open source

DOI
10.3390/ph19091455
Published
2026 Sep 14
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091455,
  title = {Therapeutic Resistance in Melanoma: Molecular Mechanisms and Emerging Pharmaceutical Strategies.},
  author = {Moussallem N and Awada A and El Darzi R and Tarhini A and Khaled A and Ashy C and Nasr W and El Masri A and Saad G and Itani M and Rizkallah J and Charbel N and Hatahet Z and Saade D and Abou Rahal J and Kreidieh F},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19091455},
  url = {https://doi.org/10.3390/ph19091455}
}

RIS

TY  - JOUR
TI  - Therapeutic Resistance in Melanoma: Molecular Mechanisms and Emerging Pharmaceutical Strategies.
AU  - Moussallem N
AU  - Awada A
AU  - El Darzi R
AU  - Tarhini A
AU  - Khaled A
AU  - Ashy C
AU  - Nasr W
AU  - El Masri A
AU  - Saad G
AU  - Itani M
AU  - Rizkallah J
AU  - Charbel N
AU  - Hatahet Z
AU  - Saade D
AU  - Abou Rahal J
AU  - Kreidieh F
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19091455
UR  - https://doi.org/10.3390/ph19091455
ER  - 

APA

N, M., A, A., R, E. D., A, T., A, K., C, A., W, N., A, E. M., G, S., M, I., J, R., N, C., Z, H., D, S., J, A. R., & F, K. (2026). Therapeutic Resistance in Melanoma: Molecular Mechanisms and Emerging Pharmaceutical Strategies.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19091455

Source records